Gastroenterology Research and Practice / 2012 / Article / Tab 2

Research Article

Probiotics, Symptoms, and Gut Microbiota: What Are the Relations? A Randomized Controlled Trial in Subjects with Irritable Bowel Syndrome

Table 2

“Treatment effect” (increase during active treatment minus increase during placebo treatment) on symptoms, proportions of the fecal microbiota, and on fecal diversity.

VariablesMean95% CI of the meanStatistics
(P values)

IBS symptom score1.570.10; 3.05P = 0.04
Bacteroides−0.01−0.11; 0.08ns (P = 0.77)
Faecalibacterium−0.03−0.18; 0.12ns (P = 0.63)
Lachnospiraceae0.05−0.03; 0.13ns (P = 0.18)
“Common” Simpson’s D−0.04−0.15; 0.08ns (P = 0.50)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.